中文名称: | Didox | ||||
---|---|---|---|---|---|
英文名称: | Didox | ||||
别名: | 3,4-二羟基苯甲羟肟酸 NSC-324360 | ||||
CAS No: | 69839-83-4 | 分子式: | C7H7NO4 | 分子量: | 169.13 |
CAS No: | 69839-83-4 | ||||
分子式: | C7H7NO4 | ||||
分子量: | 169.13 | ||||
EINEC: | 7909 | ||||
EINEC: | 7909 |
基本信息
产品编号:D10804 |
|||||
产品名称:Didox |
|||||
CAS: |
69839-83-4 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
六个月 |
||
分子量 |
169.13 |
-20℃ |
一个月 |
||
化学名: |
|||||
Solubility (25°C) |
体外 |
DMSO |
100mg/mL (591.26mM; Need ultrasonic) |
||
Ethanol |
|
||||
Water |
|
||||
体内 |
现配现用 |
|
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
5.9126mL |
29.5631mL |
59.1261mL |
5mM |
1.1825mL |
5.9126mL |
11.8252mL |
10mM |
0.5913mL |
2.9563mL |
5.9126mL |
生物活性
产品描述 |
一种合成的核糖核苷酸还原酶 (ribonucleotide reductase, RR) 抑制剂。 |
靶点/IC50 |
Ribonucleotide reductase |
体外研究 |
Didox (NSC-324360) suppresses LPS-induced mRNA levels of iNOS, IL-6, IL-1, TNF-α, NF-κβ (p65), and p38-α, after 24 h of treatment. Treatment with Didox also suppresses the secretion of nitric oxide (NO), IL-6, and IL-10. Using mitochondrial dehydrogenase activity as a measure of cytotoxicity, the effects of Didox on cellular respiration in RAW264.7 are examined over a range of concentrations for 24h. Cells exposures to 200μM and below Didox, with and without LPS, do not exhibit significant cellular toxicity. Didox (NSC-324360) is active against all human and murine acute myeloid leukemia (AML) lines tested with IC50 values in the low micromolar range (mean IC50 37 µM [range 25.89-52.70 µM]). |
体内研究 |
Once engraftment is established by bioluminescent imaging, the animals receive daily administrations of Didox at 425mg/kg via IP injection over 5 days. Didox (NSC-324360) treatment significantly reduces leukemic burden compared to vehicle treated controls (p=0.0026 and p=0.0342). More importantly, Didox (NSC-324360) provides a significant survival benefit(p<0.0001 and p=0.0094). |
推荐实验方法(仅供参考)
细胞实验: |
|
Cell Assay |
RAW264.7 macrophages are treated with Didox alone, with 0.1μg/mL LPS, or the two in combination. Cellular respiration, as an indication of cytotoxicity, is measured by the MTT assay, which quantifies mitochondrial dehydrogenase activity. Macrophages are plated into 96 well Costar plates at 105 cells per well in 100μL of DMEM media. After 4h of incubation at 37°C for adherence, compounds and DMSO carrier control (0.01% final) are added in triplicate over serial dilutions beginning with 200μM per well in a total volume of 200μL, and the plates incubated for 24 h. Four h before termination of the assay, each well receives 20μL of a 5 mg/mL MTT solution in un-supplemented DMEM. After centrifugation, the supernatant for each well is discarded and cells containing reduced MTT are solubilized with 100μL of acidified isopropanol(4 mM HCl, 0.1% NP-40 in isopropanol). Following a brief period of shaking, the optical density (O.D.) for each well is recorded at 550nm. Each experiment is repeated three times and the data averaged from each triplicate, then expressed as percentage of the control O.D. values for each experiment |
动物实验: |
|
Animal Administration |
Mice Luciferase-tagged leukemia cells are transplanted into 8- week old, sublethally irradiated (4.5Gy) C57Bl/6 mice by tail vein injection of 1.0×106 cells per mouse. Mice are injected with 150mg/kg D-Luciferin, anesthetised with Isoflurane, and imaged using the IVIS 100 imaging system. Mice begin treatment with Didox upon detection of clear signal. The animals are treated with daily administrations of Didox (NSC-324360) at 425mg/kg Didox by intraperitoneal injection (IP) for 5 days. Control animals receive 5% dextrose water by IP injection. Repeat imaging is performed on the day following the final treatment. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )